Abbott Says Whistleblower Waived False Claims Intent Argument

Jan. 23, 2023, 3:33 PM UTC

Abbott Laboratories Inc., Arriva Medical LLC, and Alere Inc. urged the US Supreme Court not to reinstate a whistleblower’s suit alleging improper billing for diabetic testing supplies.

Troy Olhausen contends that an appeals court relied on an incorrect scienter standard when it rejected his False Claims Act suit. The complaint plausibly alleges that the defendants acted with knowledge that they were violating the law, he said in his petition challenging the ruling.

But Olhausen waived the ability to challenge this issue by not raising it at the district court or at the US Court of Appeals for the Eleventh ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.